Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 36,255Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Knight Therapeutics Inc

02 1Purdue Pharma

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Knight Therapeutics Inc

arrow
Peptide Process CMC
Not Confirmed

Knight Therapeutics Inc

Country
arrow
Peptide Process CMC
Not Confirmed

Aloxireg, Netupitant

Brand Name : AKYNZEO

Patent Number : 2666512

Filing Date : 2007-10-19

Strength per Unit : 300 mg / 0.5 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-10-19

Date Granted : 2014-05-27

blank

02

Purdue Pharma

arrow
Peptide Process CMC
Not Confirmed

Purdue Pharma

Country
arrow
Peptide Process CMC
Not Confirmed

Aloxireg, Netupitant

Brand Name : AKYNZEO

Patent Number : 2299139

Filing Date : 2000-02-23

Strength per Unit : 300 mg / 0.5 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-02-23

Date Granted : 2011-03-29

blank

03

Knight Therapeutics Inc

arrow
Peptide Process CMC
Not Confirmed

Knight Therapeutics Inc

Country
arrow
Peptide Process CMC
Not Confirmed

Aloxireg, Netupitant

Brand Name : AKYNZEO

Patent Number : 2778301

Filing Date : 2010-11-18

Strength per Unit : 300 mg / 0.5 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-11-18

Date Granted : 2016-06-14

blank